REFERNCE

The contract pertains to the procurement of a Reference Standard, Blood Chemistry, specifically the CellCheck 400, 10 mL ampule stabilized latex particle solution with a diameter of 4 to 5 microns, intended for quality control monitoring of calibration, accuracy, and precision in blood chemistry analyzers. The item is identified by NSN 6630-01-729-3509, with a quantity of two boxes, each containing 50 ampules arranged on five trays, and must be stored at room temperature until expiration without freezing. Delivery is required within 20 days as directed under an as-directed or as-received order (ADO/ARO), with the point of delivery designated as destination, and FOB terms specify destination delivery responsibility. The shelf life requirement mandates a minimum 24-month expiration period from manufacture, with no more than three months elapsed from production to delivery, and all packaging must comply with MIL-STD-2073-1E and DLA’s RP001 packaging standards. Labeling must adhere to Medical Marking Standard No. 1, including dates of manufacture and expiration, contract number, and lot number, while hazardous material handling requires compliance with GHS and OSHA Hazard Communication Standard, including submission of safety data sheets and approved labels prior to award. The solicitation number is SPE2DH-26-T-3518, issued by the Department of Defense’s Medical Supply Chain FSH, with a response deadline of May 6, 2026, and submissions must be made via the DIBBS portal. Full compliance is required with FAR clauses including 52.216-1 for contract type determination, 52.246-2 for destination inspection, 52.223-3 for hazardous material identification, and multiple DFARS clauses governing cybersecurity, whistleblower rights, employment eligibility, and trafficking in persons. Invoicing is to be processed exclusively through WAWF, using DoDAAC codes for financial routing, and no pricing information is currently populated, leaving the contract value undetermined. The contractor is responsible for all packaging, preservation, labeling, and documentation, with inspection conducted upon arrival at the destination by government personnel, and all deliverables must meet FDA regulatory expectations for medical devices as applicable.